These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35241740)

  • 21. Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: An analysis from a prospective cohort.
    Qi WX; Wang X; Li C; Li S; Li H; Xu F; Chen J; Zhao S; Li H
    Thorac Cancer; 2023 Jun; 14(17):1556-1566. PubMed ID: 37089116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Prognostic Significance of Nomogram-Based Pretreatment Inflammatory Indicators in Patients With Esophageal Squamous Cell Carcinoma Receiving Intensity-Modulated Radiotherapy.
    Xu Z; Ke H; Zheng B; Lin C; Zhang Y; Wang L; Lin Y; Ye Y; Cai L; You M; Chen J; Xu Y
    Cancer Control; 2023; 30():10732748231185025. PubMed ID: 37339928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of sarcopenia and inflammatory indices synergy in patients with esophageal squamous cell carcinoma undergoing chemoradiotherapy.
    Xiao L; Liu Y; Zhang X; Nie X; Bai H; Lyu J; Li T
    BMC Cancer; 2024 Jul; 24(1):860. PubMed ID: 39026185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy.
    Ji WH; Jiang YH; Ji YL; Li B; Mao WM
    Dis Esophagus; 2016 Jul; 29(5):403-11. PubMed ID: 25625421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognostic analysis of definitive radiotherapy for early esophageal carcinoma(T1-2N0M0): a multi-center retrospective study of Jing-Jin-ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group].
    Lu N; Wang X; Li C; Wang L; Chen JQ; Zhang WC; Wang XM; Ge XL; Shen WB; Hu MM; Yuan QQ; Xu YG; Hao CL; Zhou ZG; Qie S; Xiao ZF; Zhu SC; Han C; Qiao XY; Pang QS; Wang P; Zhao YD; Sun XC; Zhang KX; Li L; Li GF; Liu ML; Wang YD
    Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):139-144. PubMed ID: 32135649
    [No Abstract]   [Full Text] [Related]  

  • 26. The preoperative systemic immune-inflammation index is associated with an unfavorable prognosis for patients undergoing curative resection of esophageal squamous cell carcinoma after neoadjuvant therapy.
    Obata Y; Kanda M; Shimizu D; Takami H; Inokawa Y; Hattori N; Hayashi M; Tanaka C; Nakayama G; Kodera Y
    Surg Today; 2023 Aug; 53(8):964-972. PubMed ID: 36797438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study on the predictive value of pretreatment peripheral blood inflammatory markers regarding immunotherapy in patients with inoperable advanced or locally advanced oesophageal squamous cell carcinoma.
    Fu M; Li Z; Ma J; Shen F; Zhang X
    Scand J Gastroenterol; 2024 Jun; 59(6):722-729. PubMed ID: 38362884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.
    Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P
    World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
    Zhou XL; Li YQ; Zhu WG; Yu CH; Song YQ; Wang WW; He DC; Tao GZ; Tong YS
    Sci Rep; 2017 Feb; 7():42581. PubMed ID: 28195186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Preoperative Neutrophil-To-Lymphocyte Ratio Is a Novel Immune Parameter for the Prognosis of Esophageal Basaloid Squamous Cell Carcinoma.
    Xiao Q; Zhang B; Deng X; Wu J; Wang H; Wang Y; Wang W
    PLoS One; 2016; 11(12):e0168299. PubMed ID: 27959959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of preoperative fibrinogen and neutrophil to lymphocyte ratio is a predictive prognostic factor in ESCC and AEG systematic review.
    Tianxing G; Xiaojie P; Lihuan Z; Yangyun H
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31511434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High fibrinogen-albumin ratio index (FARI) predicts poor survival in head and neck squamous cell carcinoma patients treated with surgical resection.
    Wang S; Feng Y; Xie Y; Zhao X; Ma J; Liu X; Hu C; Hou T
    Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4541-4548. PubMed ID: 35462579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma.
    Han LH; Jia YB; Song QX; Wang JB; Wang NN; Cheng YF
    Asian Pac J Cancer Prev; 2015; 16(6):2245-50. PubMed ID: 25824745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.
    Ning ZH; Zhao W; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT
    Int J Clin Exp Pathol; 2015; 8(6):6881-90. PubMed ID: 26261575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Albumin-Derived NLR Score is a Novel Prognostic Marker for Esophageal Squamous Cell Carcinoma.
    Abe T; Oshikiri T; Goto H; Kato T; Horikawa M; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Kakeji Y
    Ann Surg Oncol; 2022 Apr; 29(4):2663-2671. PubMed ID: 34807322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of the neutrophil-to-lymphocyte ratio for overall and disease-free survival in patients with surgically treated esophageal squamous cell carcinoma.
    Jung J; Park SY; Park SJ; Park J
    Tumour Biol; 2016 Jun; 37(6):7149-54. PubMed ID: 26662960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of systemic inflammatory response markers in patients with superficial esophageal squamous cell carcinomas.
    Chen CJ; Lee CT; Tsai YN; Tseng CM; Chen TH; Hsu MH; Wang CC; Wang WL
    Sci Rep; 2022 Oct; 12(1):18241. PubMed ID: 36309551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of preoperative Nutritional Risk Screening-2002 combined with hematologic inflammatory markers on prognosis of thoracic esophageal squamous cell carcinoma].
    Guo XW; Zhu L; Ye HX; Zhou SB; Liu YC; Zhou JY; Ji SJ
    Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):604-609. PubMed ID: 31434452
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical Application Value of the Prognostic Nutritional Index for Predicting Survival in Patients with Esophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy or Radiotherapy.
    Xiao L; Lyu J; Liu X; Li K; Wang Y; Zhang R; Chen T; Li T
    Nutr Cancer; 2021; 73(10):1933-1940. PubMed ID: 33044092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Albumin and Derived Neutrophil-to-Lymphocyte Ratio is a Novel Prognostic Factor for Patients with Esophageal Squamous Cell Carcinoma.
    Abe T; Oshikiri T; Goto H; Kato T; Horikawa M; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Nakamura T; Kakeji Y
    Ann Surg Oncol; 2022 Oct; 29(11):6860-6866. PubMed ID: 35622180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.